PhRMA: U.S. drugmakers harmed by India's trade policies

02/17/2014 |

India's trade policies have adversely affected U.S. drugmakers, Rod Hunter of the Pharmaceutical Research and Manufacturers of America said last week at the U.S. International Trade Commission's hearing on India's trade, investment and industrial policies. India used various policies to undermine patent rights involving 15 drugs. Patents are not a significant barrier to access of drugs in India, where the government could cut tariffs and taxes to reduce prices, Hunter said.

View Full Article in:

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT